6 ms·

I am fairly grumpy that we didn't get the Moderna SARS-CoV-2 vaccine for 2-5yos months ago. Waiting for Pfizer's data was such a strange policy choice. There ma

• bananapear 4y ago
  Are you not concerned that a lot of European countries stopped giving that one to people under 30 for safety reasons? (https://www.bmj.com/content/375/bmj.n2477 https://www.bmj.com/content/375/bmj.n2477)
  • whizzter 4y ago
    If you look at the FDA press release it does seem like they seem to have mostly narrowed down the at-risk groups since, I guess they might've also tweaked dosages at this point. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-covid-19-vaccines-children https://www.fda.gov/news-events/press-announcements/coronavi...
  • vkou 4y ago
    The risk was very minor, and was in hindsight not worth waiting for. But now that the data is in, though, when your option is two vaccines, one with very minor risk, and one with even less risk, and they are both equally effective, it's obvious that you should prefer the latter.
• whizzter 4y ago
  Not entirely sure about what this refers to, but.. 1: The Moderna vaccine is separate from Pfizer/Biontech even if they share technological base. 2: Moderna was discontinued for younger people (below 30yos) in at least some European countries due to slightly higher risk of myocarditis (even if the Pfizer vaccine had slightly lower efficiancy). Seems like both vaccines are allowed for smaller children in the US now. Over here they put the cutoff for the vaccine at 12-13yos iirc (my older kid got it but not my younger one).